Zomedica

ZOM · Other

$0.0779−$0.0011 (−1.42%)TodayMarket closed · Oct 20, 3:59 PM ET

Prev close $0.079

Latest news

Press releaseFeb 24, 7:05 AM ETBusiness Wire
Diality Appoints Peter Donato as Chief Financial Officer
Press releaseDec 11, 6:30 AM ETACCESS Newswire
Zomedica Announces Collaboration with Prime Video as Assisi Loop(R) Products Appear in New Holiday Film Merv
Press releaseDec 4, 6:30 AM ETACCESS Newswire
Zomedica Expands TRUFORMA(R) Diagnostic Menu with Launch of Equine Progesterone Assay
Press releaseNov 11, 6:30 AM ETACCESS Newswire
Zomedica Announces "Friday at Four" Webinar on November 21st Providing Strategic Overview & Third Quarter 2025 Business Review
Press releaseNov 6, 6:30 AM ETACCESS Newswire
Zomedica Achieves ISO 13485 Certification, Underscoring Strengthened Quality Infrastructure and Commercial Potential
Press releaseNov 4, 4:17 PM ETACCESS Newswire
Zomedica Announces Third Quarter 2025 Financial Results: Revenue up 16% to $8.1 Million with 67% Gross Margins and $54 Million in Liquidity to Support Growth
Press releaseOct 23, 6:30 AM ETACCESS Newswire
Zomedica Announces Launch of the Assisi Loop Lounge(R), Scientifically Backed tPEMF(TM) Therapy for Pets
Press releaseOct 14, 6:30 AM ETACCESS Newswire
Zomedica Expands Grovet's Distribution Agreement to Include Zomedica's Diagnostic and Therapeutic Device Products Across the European Union
Press releaseOct 9, 6:30 AM ETACCESS Newswire
Zomedica to Spotlight VETGuardian(R) Zero Touch(TM) Monitor in October "Fourth Friday at Four" Webinar
Press releaseSep 23, 6:30 AM ETACCESS Newswire
Zomedica Expands TRUFORMA(R) Diagnostic Platform with Addition of Feline Use to Cobalamin & Folate Assay
Press releaseSep 18, 6:30 AM ETACCESS Newswire
Zomedica Expands TRUVIEW(R) and TRUFORMA(R) Intellectual Property Portfolio with Four Newly Issued U.S. Patents
Press releaseSep 12, 6:30 AM ETACCESS Newswire
Zomedica's Fourth Friday at Four Webinar Returns: Spotlight on TRUVIEW(R) Digital Cytology Microscope - Transforming Veterinary Imaging
Press releaseSep 10, 6:30 AM ETACCESS Newswire
Zomedica and UXR Announce Expanded Distribution Agreement in Canada
Press releaseSep 3, 6:30 AM ETACCESS Newswire
Zomedica Strengthens UK Market Position with Strategic Distribution Agreement for High-Growth Veterinary Innovation Portfolio
Press releaseAug 19, 6:30 AM ETACCESS Newswire
Zomedica and VerticalVet Announce Strategic Partnership to Deliver Advanced Veterinary Technologies to Independent Practices
Press releaseAug 12, 6:30 AM ETACCESS Newswire
Zomedica's Fourth Friday at Four Webinar Returns: Spotlight on the VETIGEL(R) Hemostatic Product - The Future of Rapid Bleeding Control in Veterinary Medicine
Press releaseAug 6, 4:12 PM ETACCESS Newswire
Zomedica Announces Second Quarter 2025 Financial Results: Revenue up 14% to $7 Million with 67% Gross Margins and $59 Million in Liquidity to Support Growth
Press releaseJul 16, 6:00 AM ETACCESS Newswire
Zomedica's Fourth Friday at Four Webinar Returns: Spotlight on the Assisi(R) Line - Advancing Drug-Free Healing for Pets
Press releaseJul 10, 6:30 AM ETACCESS Newswire
Zomedica Announces Strategic PulseVet(R) Shock Wave Partnership with World Equestrian Center – Ocala
Press releaseJun 24, 6:30 AM ETACCESS Newswire
Zomedica Announces Issuance of Additional Patent for its TRUVIEW(R) Microscope
Press releaseJun 19, 6:30 AM ETACCESS Newswire
Zomedica's Fourth Friday at Four Webinar Returns: Spotlight on TRUFORMA Diagnostic Platform(R) - Revolutionizing In-Clinic Diagnostics
Press releaseMay 21, 6:30 AM ETACCESS Newswire
Zomedica Launches Enhanced Equine Insulin Assay for the TRUFORMA(R) Diagnostic Platform Featuring an Extended Range and Automatic Sample Dilution
Press releaseMay 19, 6:15 PM ETACCESS Newswire
Zomedica Unveils Exclusive Fourth Friday at Four Webinar Series to Explore Cutting-Edge Veterinary Innovations
Press releaseMay 13, 6:30 AM ETACCESS Newswire
Zomedica Launches Groundbreaking Equine Asthma Clinical Registry Featuring PulseVet(R) Shock Wave Therapy
NewsMar 13, 4:32 AM ET
Earnings Scheduled For March 13, 2025
Press releaseMar 4, 5:30 PM ETACCESS Newswire
Zomedica Corp. Announces Transition to OTCQB Venture Market
NewsMar 4, 9:54 AM ET
Zomedica Shares Halted, News Pending
Press releaseNov 7, 4:25 PM ETACCESSWIRE
Zomedica Announces Third Quarter 2024 Financial Results: Revenue Up 10% to $7 Million; 72% Gross Margin, and $78 Million in Liquidity to Support Growth

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.

Latest news

Diality Appoints Peter Donato as Chief Financial Officer

Zomedica Announces Collaboration with Prime Video as Assisi Loop(R) Products Appear in New Holiday Film Merv

Zomedica Expands TRUFORMA(R) Diagnostic Menu with Launch of Equine Progesterone Assay

Zomedica Announces "Friday at Four" Webinar on November 21st Providing Strategic Overview & Third Quarter 2025 Business Review

Zomedica Achieves ISO 13485 Certification, Underscoring Strengthened Quality Infrastructure and Commercial Potential

Zomedica Announces Third Quarter 2025 Financial Results: Revenue up 16% to $8.1 Million with 67% Gross Margins and $54 Million in Liquidity to Support Growth

Zomedica Announces Launch of the Assisi Loop Lounge(R), Scientifically Backed tPEMF(TM) Therapy for Pets

Zomedica Expands Grovet's Distribution Agreement to Include Zomedica's Diagnostic and Therapeutic Device Products Across the European Union

Zomedica to Spotlight VETGuardian(R) Zero Touch(TM) Monitor in October "Fourth Friday at Four" Webinar

Zomedica Expands TRUFORMA(R) Diagnostic Platform with Addition of Feline Use to Cobalamin & Folate Assay

Zomedica Expands TRUVIEW(R) and TRUFORMA(R) Intellectual Property Portfolio with Four Newly Issued U.S. Patents

Zomedica's Fourth Friday at Four Webinar Returns: Spotlight on TRUVIEW(R) Digital Cytology Microscope - Transforming Veterinary Imaging

Zomedica and UXR Announce Expanded Distribution Agreement in Canada

Zomedica Strengthens UK Market Position with Strategic Distribution Agreement for High-Growth Veterinary Innovation Portfolio

Zomedica and VerticalVet Announce Strategic Partnership to Deliver Advanced Veterinary Technologies to Independent Practices

Zomedica's Fourth Friday at Four Webinar Returns: Spotlight on the VETIGEL(R) Hemostatic Product - The Future of Rapid Bleeding Control in Veterinary Medicine

Zomedica Announces Second Quarter 2025 Financial Results: Revenue up 14% to $7 Million with 67% Gross Margins and $59 Million in Liquidity to Support Growth

Zomedica's Fourth Friday at Four Webinar Returns: Spotlight on the Assisi(R) Line - Advancing Drug-Free Healing for Pets

Zomedica Announces Strategic PulseVet(R) Shock Wave Partnership with World Equestrian Center – Ocala

Zomedica Announces Issuance of Additional Patent for its TRUVIEW(R) Microscope

Zomedica's Fourth Friday at Four Webinar Returns: Spotlight on TRUFORMA Diagnostic Platform(R) - Revolutionizing In-Clinic Diagnostics

Zomedica Launches Enhanced Equine Insulin Assay for the TRUFORMA(R) Diagnostic Platform Featuring an Extended Range and Automatic Sample Dilution

Zomedica Unveils Exclusive Fourth Friday at Four Webinar Series to Explore Cutting-Edge Veterinary Innovations

Zomedica Launches Groundbreaking Equine Asthma Clinical Registry Featuring PulseVet(R) Shock Wave Therapy

Earnings Scheduled For March 13, 2025

Zomedica Corp. Announces Transition to OTCQB Venture Market

Zomedica Shares Halted, News Pending

Zomedica Announces Third Quarter 2024 Financial Results: Revenue Up 10% to $7 Million; 72% Gross Margin, and $78 Million in Liquidity to Support Growth